my account
log out
|
|
my account
log out
|
Afuco™ Anti-Human ACVR2B ADCC Theraputic Antibody (ANB012), ADCC Enhanced |
| Create: 07/26/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-ACVR2B ADCC Enhanced Antibody (ANB012) is an ADCC enhanced antibody produced by our Afuco™ platform. ANB012 is a pre-clinical antibody that antagonizes ActRIIB. ActRIIB antagonism has been shown to downregulate a variety of factors that lead to muscle loss and wasting. https://www.creativebiolabs.net/Anti-ACVR2B-ADCC-Enhanced-Antibody-ANB012-20317.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 232 | |
| Feb 01 2023 | GVBE Buffer | 232 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 239 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 227 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 420 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 501 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 410 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 427 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 408 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 435 |
| Copyright © toextrade Inc. All rights reserved. Contact us |